Company profileLarge company (from the award notice)
ALK - Abelló Arzneimittel GmbH
- Legal form
- GmbH
- Seat
- Hamburg, Germany
Based on the notices and sources Inteliwert covers; not a complete record. Last checked 1 November 2024.
Identifiers
As the covered sources state them.
- Register entry
- HRB 126385
Track record in public tenders
Awards in the covered notices over the last 36 months, per CPV division.
| CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award |
|---|---|---|---|---|---|---|
| 33 Medical equipments, pharmaceuticals and personal care products | 1 | — | 1 | 0 | 1 November 2024 | 1 November 2024 |
Awards
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkst. Allergenextrakt div. Urspr. (Subkutanspritzen; V01AA02, V01AA03, V01AA05), für die Zeit 01.11.2024 - 31.10.2026Buyer: DAK-Gesundheit · Awarded: 1 November 2024 · CPV 33600000
Certifications and prequalification
No certification or prequalification found in the covered sources.
A certification missing here is unknown, not absent.
Website and LinkedIn
Not found in the indexed notices.
Open tenders that might fit
Possible match based on public information
Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.
-
OpenTenderEstablished supplierNew to public tenders
Open-House-Rabattverträge 2026-21 Lisdexamfetamin (90 St.)
Reasons
- Won a contract in CPV group 336 (2024-11-01) Evidence · checked 1 Nov 2026
- Seat in the same district as the place of performance Evidence · checked 1 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 1 Nov 2026
Last checked 4 Nov 2026, 13:10 (UTC+01:00)Official notice -
OpenTenderEstablished supplierNew to public tenders
Open House Biologika Rabattverträge 2026 - 29 Rituximab (nur Fertigarzneimittel)
Reasons
- Won a contract in CPV group 336 (2024-11-01) Evidence · checked 2 Nov 2026
- Seat in the same district as the place of performance Evidence · checked 2 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 2 Nov 2026
Last checked 6 Nov 2026, 12:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplierNew to public tenders
Open-House-Rabattverträge 2026-18
Reasons
- Won a contract in CPV group 336 (2024-11-01) Evidence · checked 4 Nov 2026
- Seat in the same district as the place of performance Evidence · checked 4 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 28 Oct 2026, 06:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplierNew to public tenders
Open-House-Rabattverträge 2026-19 Adalimumab
Reasons
- Won a contract in CPV group 336 (2024-11-01) Evidence · checked 5 Nov 2026
- Seat in the same district as the place of performance Evidence · checked 5 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 5 Nov 2026
Last checked 4 Nov 2026, 16:10 (UTC+01:00)Official notice -
OpenTenderEstablished supplierNew to public tenders
Open House Biologika Rabattverträge 2026-32 Aflibercept
Reasons
- Won a contract in CPV group 336 (2024-11-01) Evidence · checked 6 Nov 2026
- Seat in the same district as the place of performance Evidence · checked 6 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 6 Nov 2026
Last checked 4 Nov 2026, 15:10 (UTC+01:00)Official notice -
OpenTenderEstablished supplierNew to public tenders
Open House Biologika Rabattverträge 2026 - 31 Ranibizumab
Reasons
- Won a contract in CPV group 336 (2024-11-01) Evidence · checked 6 Nov 2026
- Seat in the same district as the place of performance Evidence · checked 6 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 6 Nov 2026
Last checked 4 Nov 2026, 15:10 (UTC+01:00)Official notice -
OpenTenderEstablished supplierNew to public tenders
Open-House-Rabattverträge 2025-07
Reasons
- Won a contract in CPV group 336 (2024-11-01) Evidence · checked 6 Nov 2026
- Seat in the same district as the place of performance Evidence · checked 6 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 6 Nov 2026
Last checked 6 Nov 2026, 14:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplierNew to public tenders
Open-House-Rabattverträge 2024-11
Reasons
- Won a contract in CPV group 336 (2024-11-01) Evidence · checked 6 Nov 2026
- Seat in the same district as the place of performance Evidence · checked 6 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 6 Nov 2026
Last checked 6 Nov 2026, 14:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplierNew to public tenders
Open-House-Originale-Rabattverträge 2026-14 Crizotinib
Reasons
- Won a contract in CPV group 336 (2024-11-01) Evidence · checked 6 Nov 2026
- Seat in the same district as the place of performance Evidence · checked 6 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 6 Nov 2026
Last checked 6 Nov 2026, 15:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplierNew to public tenders
Open-House-Rabattverträge 2026-11 - Dorzolamid ATR (EDO)
Reasons
- Won a contract in CPV group 336 (2024-11-01) Evidence · checked 3 Nov 2026
- Seat in the same district as the place of performance Evidence · checked 3 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 07:30 (UTC+01:00)Official notice
Is this your company?
Send corrections, or ask us to remove the profile, to hello@inteliwert.com. You can also ask that the company never be tagged on LinkedIn.
About this profile
Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.
Based on the notices and sources Inteliwert covers; not a complete record.
Last checked 1 November 2024.